Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Registration of capital increase and admission to trading

As stated in company announcement no. 2, 10 June 2020, the offering of a maximum of 4,691,860 new shares in LED iBond International A/S was fully subscribed. Today, the capital increase was registered with the Danish Business Authority, and the offering has been completed. Following the capital increase, the share capital of the company is nominally DKK 634,593, divided into 12,691,860 shares with a nominal value of DKK 0.05 each. Nasdaq First North Growth Market Denmark has confirmed that the company’s shares will be admitted to trading under the ticker ‘LEDIBOND’ and ISIN code

Report of the Annual General Meeting of Shareholders (“AGM”) in Ayima Group AB

The annual general meeting of shareholders (“AGM”) in Ayima Group AB was held today, 12 June 2020, in Stockholm. The AGM resolved unanimously in accordance with the board’s proposals and a summary of the resolutions taken by the AGM follows. For complete details concerning all resolutions, please see the basis for resolutions by the annual general meeting, which is available on the company’s website at https://www.ayima.com/investors.   ● The AGM resolved to adopt the income statement and balance sheet and the consolidated income statement and consolidated balance sheet.● The AGM

Lyxor ETF consolidates its leadership in the green bonds segment with more than EUR 300 million in assets under management

Lyxor is delighted to announce that its Lyxor Green Bond (DR) UCITS ETF – Acc now has more than EUR 300 million in assets under management, making it the world’s biggest green bond ETF in terms of AUM (1). This underscores the resilience of the ESG ETF market during the volatility resulting from the COVID-19 crisis. Launched in February 2017 and tracking the Solactive Green Bond EUR USD IG index, this ETF invests in investment-grade green bonds denominated in euros and US dollars. These bonds are issued by supranationals, local authorities, corporations, banks and development banks to

Annual general meeting in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 16 - 12 JUNE 2020 On Friday 12 June 2020, the annual general meeting in Dampskibsselskabet NORDEN A/S was held, see company announcement no. 14 of 20 May 2020. Adoption of the annual report The annual general meeting adopted the annual report Dividend The Board of Directors’ proposal for the distribution of the results for the year, including the payment of dividend of DKK 2,5 per share of DKK 1 for 2019, was adopted. Election of members for the Board of Directors Klaus Nyborg, Johanne Riegels Østergård, Karsten Knudsen, Thomas Intrator, Helle

Hamlet Pharma builds for a promising future

Hamlet Pharma is proud to announce that the contract with the European union has been signed, granting pre-payment of the 23 million SEK EU Accelerator grant that was awarded to the company this spring.  With this funding secured, Hamlet Pharma can now introduce a new corporate structure, strengthening our expertise and leadership in finance, business development and specific business areas.The company has put in place an Executive committee, with Anders Wihlborn as financial advisor, the CEO Mats Persson, the chairman of the board Catharina Svanborg and Jan Zetterberg, whose extensive

ChromoGenics is part of the EU's Horizon 2020 project, NewSkin

ChromoGenics is one of the participants in a consortium around the EU project, NewSkin. The project will last for four years and ChromoGenic's part in the project has a contribution of over SEK 2 million.The NewSkin project aims to create what is called an “Open Innovation Test Bed (OITB)” to develop new nano-materials for both industrial and consumer products. The project is expected to last for four years. For ChromoGenic's part, the NewSkin project will use the company's newly acquired and for Northern Europe completely unique sputtering capabilities to produce various new materials.

TI condemns spying on journalists, academics and civil society organisations

Transparency International and Poder Ciudadano, its chapter in Argentina , are deeply concerned at media reports that in 2018 the national intelligence agency was monitoring, gathering information and keeping files on journalists, academics and Civil Society Organisations that apparently registered to participate in World Trade Organisation meetings. This includes intelligence gathered on members of Poder Ciudadano’s own staff. Reports suggest that personal information was collected beyond that publicly available or on official

Trading update

Oslo, Norway (12 June 2020)  - NattoPharma continues to see a strong demand for our products during the second quarter, and we are experiencing Q2 revenue to be in the range of NOK 44-54 million resulting in a H1-2020 revenue in the range of NOK 100-110 million. This is more than 70% growth compared to H1-2019. The Adj. EBITDA margin is expected to be in excess of 15% for H1-2020, compared to the current guiding of 10-15% for the full year. The current performance builds on our confidence to deliver on the guiding for the full year as communicated during the Q1 release. During the second

Tokmanni to open a store in Kalasatama, Helsinki in October – The REDI shopping centre store will be Tokmanni’s ninth store in Helsinki

Tokmanni     Press release     12 June 2020 at 1:00 p.m. Tokmanni , Finland's largest general discount retailer, will open a new and versatile store in the REDI shopping centre  in Kalasatama, Helsinki in October this year. The store will respond to numerous customer requests and increase the number of Tokmanni stores in Helsinki to nine. The Tokmanni located at street level (1st floor) on the Sköne side of the shopping centre will offer a wide and attractive assortment of beauty, health and wellbeing, interior decoration,

Wulff Group Plc completes the repurchases of its own shares

STOCK EXCHANGE RELEASE JUNE 12, 2020 AT 1.00 P.M. Wulff Group Plc completes the repurchases of its own shares. As communicated on May 20, 2020, the Board of Directors of Wulff Group Plc decided to start repurchasing its own shares in accordance with the authorization granted by the Annual General Meeting on April 23, 2020. The repurchases started on May 25, 2020 and ended on June 11, 2020. During this time Wulff Group Plc repurchased 65,260 shares, which corresponds to approximately 0.94% of the total number of Wulff Group Plc shares. The shares were acquired at the market price

Lifting Handicare to better performance: Capital Markets Update 2020

Today, Handicare, a market leader in stairlifts, will arrange a webcasted Capital Markets Update where senior management will elaborate on the company’s strategy and the Lift Up Program.Handicare operates in a growing market with attractive underlying long-term growth fundamentals. The company holds a leading position in Europe within the Accessibility area and has a strong growth trajectory in North America. Performance within the Accessibility business unit has been solid with an organic CAGR of approximately 7 percent over the last five years, and the Group’s financial position is strong.

3Shape Appoints Jakob Just-Bomholt as New Chief Executive Officer

Copenhagen, June 12, 2020: 3Shape today announced that the Company’s Board of Directors has appointed Jakob Just-Bomholt as Chief Executive Officer, effective August 1st. Jakob leaves a position as Executive Vice President of Falck A/S, a global emergency and health care company. Prior to joining Falck in 2017, Jakob worked in various top executive positions at the shipping and logistics company, A.P. Moller-Maersk. 3Shape’s current Co-CEOs and Co-founders Tais Clausen and Nikolaj Deichmann will remain active at 3Shape in new roles as Co-Vice chairmen of the board. Jørgen

DexTech's Phase IIb study for OsteoDex ends with positive follow-up results

The company's randomized Phase IIb study for the treatment of bone metastatic castration-resistant prostate cancer (mCRPC) has now been completed with 2-year follow-up results from the last patients. The primary endpoints of the study concerning markers of bone metabolism have been well achieved. A clear majority of patients showed reduction in their skeletal markers in the blood of the given treatment with OsteoDex. Treatment was very well tolerated  (few and mild side effects)  and good disease-slowing effect was also seen in the lowest doses. The slowing down and decline of the

New agreements signal construction start-up for the next development phase of Oasen Center in Norway

CITYCON OYJ Corporate Press Release 12 June 2020Citycon signs agreements with Bergen municipality for a new health center, and with Veidekke for construction of the next development phase of Oasen Center in Bergen, Norway. Citycon has given the contractor Veidekke the assignment to complete the next phase in the development of Oasen Center in Bergen. Over 6,000 square meters of office space will be converted into premises for a new health center, F&B and daily shopping.“Citycon’s assets are located in the heart of the community, in some of the city’s most dynamic and popular

Regulatory approvals obtained for Atlas Copco’s acquisition of ISRA VISION

Nacka, Sweden, June 12, 2020: With the approval by the Committee on Foreign Investment in the United States (CFIUS) now obtained, all offer conditions for Atlas Copco’s acquisition of ISRA VISION have been fulfilled.The voluntary public takeover offer of the global machine vision specialist was announced February 10, 2020. The settlement of the offer will be completed presumably on June 24, 2020 and in connection with that a payment of MSEK 9 047 (MEUR 860) will be made to ISRA shareholders. Suspension of trading in tendered shares (ISIN DE000A254W60) will presumably take place on June 19,

Annual general meeting in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 15 - 12 JUNE 2020 Attached as separate PDF file, please find Chairman of the Board of Directors Klaus Nyborg’s oral report in full from NORDEN's annual general meeting, which is held today 12 June 2020 at 11 am CEST. The Chairman's report and the accompanying presentation (the presentation is only available in Danish) will also be made available at www.ds-norden.com from approximately 11 am CEST. A webcast (in Danish) from the annual general meeting will also be made available today after the general meeting. Kind regards Dampskibsselskabet NORDEN A/S Board

Citycon Oyj: Managers’ Transactions

CITYCON OYJ   Managers’ Transactions   12 June 2020 at 12:00 hrsPerson subject to the notification requirement: Gazit Globe Ltd., Closely associated person(X) Legal personPerson discharging managerial responsibilities in issuer: Chaim Katzman, Chairman of the Board of DirectorsIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification type: initial notificationReference number: 549300P8N0P6KDGTJ206_20200510124929_3(1) TransactionDate: 9 June 2020Venue: NASDAQ HELSINKI LTD (XHEL)Nature of the transaction: acquisitionInstrumentshare (CTY1S)ISIN Code: FI4000369947

Minesto News Update 12 June 2020

· Minesto invited as speaker at EU Sustainable Energy Week · Pareto Securities initiates coverage on Minesto · Photos: Minesto’s first offshore installation phase of the Vestmannasund project · Minesto shortlisted as finalist in the renowned E-Prize awardsMinesto invited as speaker at EU Sustainable Energy Week Minesto’s CEO Dr Martin Edlund has been invited as speaker during the EU Sustainable Energy Week, a month-long series of activities arranged by the European Commission with the purpose to build a secure energy future for Europe. This year’s theme is “Beyond the crisis:

DBP International AB: the subsidiary FarmPharma receives a grant of SEK 300,000

FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), have been granted SEK 300,000 by Vinnova in the call “Innovative Startups step 1”. The grant will support ongoing collaboration with Karolinska Institute for the production of starting materials for the company's drug candidate InterferOX. More about collaboration with Karolinska Institutet: https://mb.cision.com/Main/12720/2985377/1157822.pdf More about Vinnova: www.vinnova.se More about FarmPharma: FarmPharma AB (publ) is a subsidiary of Double Bond Pharmaceutical International AB (

New Scientific Publication with Rhinochill System in One of The Most Prestigious High Rank Medical Journal (The Intensive care medicine journal)

The publication, published online today , titled "Time to intra-arrest therapeutic hypothermia in out-of-hospital cardiac arrest patients and its association with neurologic outcome: a propensity matched sub-analysis of the PRINCESS trial" is to be part of the coming June issue of the prestigious Journal of Intensive Care Medicine (impact factor 18.97 in 2018). Intensive Care Medicine is a monthly peer reviewed medical journal covering intensive care or critical care and emergency medicine. The publication authored by the research group of the PRINCESS trial (Dr. Per Nordberg et al) and two

First Episealer® surgery in the Asia-Pacific

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the knee implant Episealer® in the Asia-Pacific region has been scheduled. “This is a significant milestone for us, and we have identified significant opportunities in the Asia-Pacific region. Recently, we have increased our focus towards several new markets, in which the regulatory work is ongoing. Scheduling the first surgery outside of Europe is exciting. We are also happy for the fact that we are reaching commercial milestones, simultaneously as we are making significant progress within the clinical strategy”

There are no items matching the current filter
There are no more items matching the current filter
Back to top